Jessica B Felix Selected Research

Neuraminidase 1 deficiency

11/2020	Correction: Intermittent enzyme replacement therapy prevents Neu1 deficiency.
1/2020	Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jessica B Felix Research Topics

Disease

2	Neuraminidase 1 deficiency 11/2020 - 01/2020
1	Inflammation (Inflammations) 01/2021
1	Hepatomegaly 01/2021
1	Obesity 12/2020
1	Insulin Resistance 12/2020
1	Hyperplasia 10/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Tauopathies 01/2020
1	Neuroblastoma 01/2020
1	Mucolipidoses (Sialidosis) 01/2020
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2020
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2020
1	GM1 Gangliosidosis (Gangliosidosis GM1) 01/2020

Drug/Important Bio-Agent (IBA)

1	LipidsIBA 01/2021
1	AdipokinesIBA 01/2021
1	CytokinesIBA 12/2020
1	InterferonsIBA 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	Heavy MetalsIBA 01/2020
1	ChromiumIBA 01/2020
1	EnzymesIBA 01/2020
1	GalactosidasesIBA 01/2020
1	5'-deoxy-5'-phosphonomethyladenosine phosphateIBA 01/2020
1	NickelIBA 01/2020
1	tau Proteins (tau Protein)IBA 01/2020

Therapy/Procedure

2	Enzyme Replacement Therapy 11/2020 - 01/2020
1	Therapeutics 01/2020